[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 48, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1717200000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.59, "open": 4.52, "dayLow": 4.12, "dayHigh": 4.59, "regularMarketPreviousClose": 4.59, "regularMarketOpen": 4.52, "regularMarketDayLow": 4.12, "regularMarketDayHigh": 4.59, "beta": 1.861, "forwardPE": -2.5396342, "volume": 460626, "regularMarketVolume": 460626, "averageVolume": 315488, "averageVolume10days": 384510, "averageDailyVolume10Day": 384510, "bid": 4.14, "ask": 4.19, "bidSize": 100, "askSize": 200, "marketCap": 198049504, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 72.94641, "fiftyDayAverage": 8.5228, "twoHundredDayAverage": 6.27396, "currency": "USD", "enterpriseValue": 87430384, "floatShares": 31888090, "sharesOutstanding": 47550900, "sharesShort": 1583371, "sharesShortPriorMonth": 1797371, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.033299997, "heldPercentInsiders": 0.13332, "heldPercentInstitutions": 0.64115995, "shortRatio": 4.19, "shortPercentOfFloat": 0.050100002, "impliedSharesOutstanding": 47550900, "bookValue": 2.711, "priceToBook": 1.5363334, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -85078000, "trailingEps": -1.93, "forwardEps": -1.64, "enterpriseToRevenue": 32.203, "enterpriseToEbitda": -1.016, "52WeekChange": 0.26595747, "SandP52WeekChange": 0.2586832, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.165, "targetHighPrice": 28.0, "targetLowPrice": 8.0, "targetMeanPrice": 15.0, "targetMedianPrice": 9.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 114633000, "totalCashPerShare": 2.411, "ebitda": -86038000, "totalDebt": 4014000, "quickRatio": 8.0, "currentRatio": 9.148, "totalRevenue": 2715000, "debtToEquity": 3.116, "revenuePerShare": 0.061, "returnOnAssets": -0.34736001, "returnOnEquity": -0.59398, "freeCashflow": -41475000, "operatingCashflow": -70928000, "revenueGrowth": 18.561, "operatingMargins": -17.976679, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-21"}]